|Bio Generation Fund, 11/06|
BioGeneration Ventures is investing in the next generation of Life Sciences companies in the Netherlands.
BioGeneration Ventures invests in Dutch start-up and early stage life sciences companies.
The BioGeneration Ventures team is specialized in the evaluation and management of early stage companies. Their involvement goes beyond the financial investment. They work closely with scientists, academic institutions, entrepreneurs and industry experts to accelerate the development and to optimize the commercial potential of their portfolio company’s technologies. BioGeneration Ventures began operating in 2006 and the fund is backed by the Netherlands Genomics Initiative (NGI) and the Netherlands Organisation for Scientific Research (NWO) in combination with the holding company of Leiden University and ABN-AMRO Capital as lead private investors.
|Lanthio Pharma||11/12||Series A||€4.8M||2|